Elanco Animal Health (NYSE:ELAN) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET

Company Participants

Katy Grissom - Head of Investor Relations
Jeffrey Simmons - President & Chief Executive Officer
Todd Young - Executive Vice President & Chief Financial Officer

Conference Call Participants

Jon Block - Stifel
Michael Ryskin - Bank of America
Umer Raffat - Evercore ISI
Chris Schott - JPMorgan
Erin Wright - Morgan Stanley
Brandon Vazquez - William Blair
Balaji Prasad - Barclays
David Westenberg - Piper Sandler

Operator

Ladies and gentlemen, thank you for standing by. Welcome to Elanco's Animal Health Second Quarter 2024 Earnings Conference Call. At this time, all lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]

I would now like to hand the call over to Katy Grissom, Head of Investor Relations. Katy, you may begin.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health's second quarter 2024 earnings call. I'm Katy Grissom, Head of Investor Relations and ESG. Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Scott Purucker from Investor Relations. The slides referenced during this call are available on the Investor Relations section of elanco.com.

Today's discussion will include forward-looking statements. These statements are based on our current assumptions and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast. For more information, see the risk factors discussed in today's earnings press release as well as in our latest Form 10-K and 10-Q filed with the SEC. We do not undertake any duty to update any forward-looking statement. Our remarks today will focus on our non-GAAP financial measures. Reconciliations of these non-GAAP measures are included in the appendix of today's slides and in the earnings press release. After our prepared remarks, we'll be happy to take your questions.

I will now turn the call over to Jeff.

Jeffrey Simmons

Thanks, Katy. Good morning, everyone. Elanco continued to deliver in the second quarter, exceeding the top end of our guidance range on our key metrics: revenue; adjusted EBITDA; and adjusted EPS. With 4 consecutive quarters of underlying revenue growth behind us, we continue to make significant progress on our 3 strategic outcomes: growing revenue; improving cash flow; and notably delivering innovation.